UPL Limited has submitted to the Exchange, the Unaudited Consolidated and Standalone financial results for the quarter ended June 30, 2025.
UPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
UPL Limited reported its Q1 FY26 results, with consolidated revenue from operations at Rs. 9,216 crore, up just ~1.6% YoY from Rs. 9,067 crore in Q1 FY25. Consolidated net loss narrowed sharply to Rs. 176 crore from a Rs. 527 crore loss a year ago, while EPS improved to Rs. (1.98) versus Rs. (5.90) in Q1 FY25 (restated for the rights issue bonus element). Exceptional items of Rs. 9 crore were recorded, mainly restructuring costs, and a non-cash loss of Rs. 112 crore arose from derecognition of impaired receivables at the Brazilian subsidiary. On the standalone (continuing operations) side, revenue jumped to Rs. 1,660 crore and PAT rose to Rs. 122 crore from Rs. 75 crore, helped by prior period reclassification of the Specialty Chemicals business as discontinued operations. Other key updates include the redemption of USD 400 million perpetual bonds by UPL Corp Mauritius, approval of the second and final rights issue call, and ongoing income-tax proceedings on overseas subsidiaries.
The sharp narrowing of the consolidated loss is a positive operational signal, though the company remains in the red and revenue growth is anaemic. Bond redemption reduces leverage, but the Rs. 112 crore Brazilian receivable hit and unresolved tax disputes on overseas subsidiaries remain overhangs for shareholders.